GE HealthCare Takes Key Role in New Consortium to Revolutionize Cancer Care, Advancing Precision Medicine for Patients in Europe
October 09, 2024
October 09, 2024
CHICAGO, Illinois, Oct. 9 -- G.E. HealthCare issued the following news release:
GE HealthCare announces the commencement, and its leading industrial role, in Thera4Care, an initiative aimed at revolutionizing the use of theranostics to broaden patient access in Europe. The Euros25.3 million project gathers 29 partners from top European academic and clinical sites, small and medium-sized enterprises, and patient advocacy groups.
Cancer is the leading cause of death world . . .
GE HealthCare announces the commencement, and its leading industrial role, in Thera4Care, an initiative aimed at revolutionizing the use of theranostics to broaden patient access in Europe. The Euros25.3 million project gathers 29 partners from top European academic and clinical sites, small and medium-sized enterprises, and patient advocacy groups.
Cancer is the leading cause of death world . . .